Zai Lab Story Overview

ZLAB -- USA Stock  

USD 22.84  0.56  2.39%

Macroaxis does not monitor all media channels or aggregates social signals for Zai Lab. But even though we do not provide professional-grade financial sentiment analysis on Zai Lab Limited, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Zai Lab. See also Your Current Watchlist.
Zai Lab Limited to present at the 36th Annual JP Morgan Healthcare Conference
Zai Lab is a Shanghai-based innovative biopharmaceutical company focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world.

Read More...   

Story Momentum

This media report from globenewswire.com distributed on January 3, 2018 was a factor to the next trading day price decrease.The trading date delta against the next closing price was 1.12% . The trading date delta when the story was published against the current closing price is 8.55% .

Similar stores for Zai Lab

Zai Lab Limited Reports Acceptance of NDA Submission of ZEJULA in Mainland China by the NMPA - StreetInsider.c...Street Insider News
Zai Lab Limited Reports Acceptance of NDA Submission of ZEJULA in Mainland China by the NMPA StreetInsider.comGet instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. Zai Lab Limited today ...
over three weeks ago at http://www.fairfieldcurrent.com 
Arvinas and Paratek Pharmaceuticals Head-To-Head Survey
news
Fairfield CurrentFull coverage
Fmr LLC Has 117.54 Million Position in Zai Lab Ltdnews
Baseball Daily NewsFull coverage
over a month ago at http://thewellesleysnews.com 
Stock-research Ratings Hewlett Packard Enterprise Company , Zai Lab Limited
news
Analyst JournalFull coverage
over a month ago at http://cardinalweekly.com 
As Bhp Billiton Lt Market Valuation Declined, Segantii Capital Management LTD Cut Position by 109.01 Million
news
The Cardinal Weekly Full coverage
over two months ago at http://cardinalweekly.com 
EPS for Five Prime Therapeutics, Inc. Expected At -1.16
news
The Cardinal Weekly Full coverage
over two months ago at http://cardinalweekly.com 
Are Analysts Bullish Five Prime Therapeutics, Inc. After Last Week
news
The Cardinal Weekly Five Prime Therapeutics Inc Institutional Investors Are Worried MoneyMakingArticlesFull coverage
over two months ago at http://cardinalweekly.com 
Does Zai Lab Limited American Depositary Shares Have Gas After Even Less Sellers Involved
news
The Cardinal Weekly Zai Lab Ltd Crawls 1.56 percent Higher For The Week Hawthorn CallerZai Lab Ltd Given Average Rating of Hold by Brokerages Marea Informative Full coverage
over two months ago at http://www.globallegalchronicle.com 
Holland And Barrett International Ltd Anor v General Nutrition Investment Company
news
Global Legal Chronicle Full coverage
over three months ago at http://www.talktraders.com 
Stock within Investors Screening Zai Lab Limited
news
Talk Traders Full coverage
over three months ago at http://thewellesleysnews.com 
Analyzing Analyst Recommendations Zai Lab Limited , ShotSpotter, Inc.
news
Analyst JournalFull coverage
over six months ago at http://malibureport.com 
Amicus Therapeutics Holding Has Lifted by Sectoral Asset Management Inc
news
The Malibu ReportSectoral Asset Management INC Position In Amicus Therapeutics Was Has Boosted BZ WeeklyFull coverage
over six months ago at http://normanweekly.com 
Kentucky Retirement Systems Insurance Trust Fund Has Cut Its Facebook Stake Zai Lab Limited American ...
news
Norman WeeklyFull coverage

Cash per Share

Cash per Share Comparative Analysis

  Cash per Share 
      Zai Lab Comparables 
Zai Lab is currently under evaluation in cash per share category among related companies. Cash per Share is a ratio of current cash on hands or in the banks of the company to total number of shares outstanding. It is used to determine firm's liquidity and is a good indicator of overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
See also Your Current Watchlist. Please also try Portfolio Reporting module to create custom reports across your portfolios and generate quick suggestion pitch.
Search macroaxis.com